{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:19:34Z","timestamp":1759331974478},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Tracheobronchial adenoid cystic carcinoma (TACC) is a rare malignancy. Surgical resection remains the standard treatment of choice. But it is frequently unresectable due to its local extension. The practicability and safety of hypofractionated radiotherapy (HRT) for TACC remains unknown since most of the TACCs are centrally located.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 57-year-old female presented with paroxysmal cough, expectoration, and hemoptysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Computed tomography (CT) scan of the chest revealed a nodule originating from the wall of right primary bronchus, with 1.9\u22171.2\u200acm in size. Bronchoscope confirmed the node on the medial wall of the right primary bronchus extending towards the carina, with a close distance of 0.5\u200acm. Biopsy from the node was considered as adenoid cystic carcinoma (ACC). The clinical stage of the patient was T3N0M0.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient underwent HRT with a total dose of 60Gy in twelve fractions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient experienced complete remission after HRT. No symptomatic radiation-induced toxicity (\u2265grade 2) was observed during the follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>HRT may be a safe and effective modality for inoperable TACC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013463","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T18:09:10Z","timestamp":1544292550000},"page":"e13463","source":"Crossref","is-referenced-by-count":3,"title":["Complete remission after hypofractionated radiotherapy for a patient with inoperable adenoid cystic carcinoma of bronchus"],"prefix":"10.1097","volume":"97","author":[{"given":"Daquan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20240524","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.athoracsur.2004.05.064","article-title":"Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina","volume":"78","author":"Gaissert","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"R2-20240524","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/JTO.0b013e31817c9245","article-title":"Adenoid cystic carcinoma of the trachea treated with PET-CT based intensity modulated radiotherapy","volume":"3","author":"Haresh","year":"2008","journal-title":"J Thorac Oncol"},{"key":"R3-20240524","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13014-017-0933-6","article-title":"A 10-year clinical outcome of radiotherapy as an adjuvant or definitive treatment for primary tracheal adenoid cystic carcinoma","volume":"12","author":"Je","year":"2017","journal-title":"Radiat Oncol"},{"key":"R4-20240524","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lungcan.2010.08.011","article-title":"Treatment outcomes of patients with adenoid cystic carcinoma of the airway","volume":"72","author":"Lee","year":"2011","journal-title":"Lung Cancer"},{"key":"R5-20240524","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5223(96)70011-9","article-title":"Adenoid cystic carcinoma of the airway: thirty-two-year experience","volume":"112","author":"Maziak","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R6-20240524","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clon.2015.02.001","article-title":"The radiobiology of hypofractionation","volume":"27","author":"Nahum","year":"2015","journal-title":"Clin Oncol"},{"key":"R7-20240524","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/JTO.0b013e31822e71d8","article-title":"Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer","volume":"6","author":"Haasbeek","year":"2011","journal-title":"J Thorac Oncol"},{"key":"R8-20240524","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2013.01.004","article-title":"Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review","volume":"106","author":"Senthi","year":"2013","journal-title":"Radiother Oncol"},{"key":"R9-20240524","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.radonc.2014.07.010","article-title":"Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications","volume":"112","author":"Li","year":"2014","journal-title":"Radiother Oncol"},{"key":"R10-20240524","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.2017.74.9671","article-title":"Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: american society of clinical oncology endorsement of the american society for radiation oncology evidence-based guideline","volume":"36","author":"Schneider","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201812070-00067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:02:00Z","timestamp":1716584520000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201812070-00067"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":10,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013463","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}